Center for Biopharmaceuticals and Biobarriers in Drug Delivery, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
Sanofi-Aventis, Industriepark Höchst, 65929 Frankfurt am Main, Germany.
J Control Release. 2021 Oct 10;338:8-21. doi: 10.1016/j.jconrel.2021.07.030. Epub 2021 Jul 21.
Delivery of therapeutic peptides upon oral administration is highly desired and investigations report that the cell-penetrating peptide (CPP) penetratin and its analogues shuffle and penetramax show potential as carriers to enhance insulin delivery. Exploring this, the specific aim of the present study was to understand the impact that their complexation with a lipidated or non-lipidated therapeutic cargo would have on the delivery, to evaluate the effect of differences in membrane interactions in vitro and in vivo, as well as to deduce the mode of action leading to enhanced delivery. Fundamental biophysical aspects were studied by a range of orthogonal methods. Transepithelial permeation of therapeutic peptide was evaluated using the Caco-2 cell culture model supplemented with epithelial integrity measurements, real-time assessment of the carrier peptide effects on cell viability and on mode of action. Pharmacokinetic and pharmacodynamic (PK/PD) parameters were evaluated following intestinal administration to rats and tissue effects were investigated by histology. The biophysical studies revealed complexation of insulin with shuffle and penetramax, but not with penetratin. This corresponded to enhanced transepithelial permeation of insulin, but not of lipidated insulin, when in physical mixture with shuffle or penetramax. The addition of shuffle and penetramax was associated with a lowering of Caco-2 cell monolayer integrity and viability, where the lowering of cell viability was immediate, but reversible. Insulin delivery in rats was enhanced by shuffle and penetramax and accompanied by a 10-20-fold decrease in blood glucose with immediate effect on the intestinal mucosa. In conclusion, shuffle and penetramax, but not penetratin, demonstrated to be potential candidates as carriers for transmucosal delivery of insulin upon oral administration, and their effect depended on association with both cargo and cell membrane. Interestingly, the present study provides novel mechanistic insight that peptide carrier-induced cargo permeation points towards enhancement via the paracellular route in the tight epithelium. This is different from the anticipated belief being that it is the cell-penetrating capability that facilitate transepithelial cargo permeation via a transcellular route.
口服给予治疗性肽是非常需要的,研究报告表明,细胞穿透肽(CPP)穿透肽及其类似物穿梭肽和穿透肽 max 具有作为载体增强胰岛素递送的潜力。探索这一点,本研究的具体目的是了解它们与脂质化或非脂质化治疗性货物复合后对递送的影响,评估体外和体内膜相互作用差异的影响,以及推断导致增强递送的作用模式。通过一系列正交方法研究了基本的生物物理方面。通过补充上皮完整性测量、实时评估载体肽对细胞活力和作用模式的影响,评估治疗性肽的跨上皮渗透。通过给予大鼠肠内给药评估药代动力学和药效学(PK/PD)参数,并通过组织学研究组织效应。生物物理研究表明,胰岛素与穿梭肽和穿透肽 max 复合,但与穿透肽不复合。这对应于胰岛素与穿梭肽或穿透肽 max 物理混合物时,胰岛素的跨上皮渗透增强,但脂质化胰岛素则不然。穿梭肽和穿透肽 max 的添加与 Caco-2 细胞单层完整性和活力降低有关,其中细胞活力降低是即时的,但可恢复的。穿梭肽和穿透肽 max 增强了胰岛素在大鼠中的递送,并伴有血糖降低 10-20 倍,对肠道黏膜有即时影响。总之,穿梭肽和穿透肽 max,但不是穿透肽,被证明是口服递送至粘膜胰岛素的潜在载体候选物,其作用取决于与货物和细胞膜的结合。有趣的是,本研究提供了新的机制见解,即肽载体诱导的货物渗透表明通过紧密上皮的旁细胞途径增强,这与预期的信念不同,即穿透细胞的能力通过细胞内途径促进跨上皮货物渗透。